Clinicians and researchers from across the MAHSC partnership came together for a meeting at the Chancellor Hotel last Monday (21September), to discuss the potential of Biomaterials in clinical practice.
The evening event was organised by Dr Alberto Saiani of the Manchester Biomaterials Group at The University of Manchester in partnership with MAHSC and the Manchester Regenerative Medicine Network, and featured discussions on reconstructive surgery and cell therapies.
Dr Adam Reid, Senior Clinical Lecturer in Plastic and Reconstructive Surgery at The University of Manchester and University Hospital of South Manchester NHS Foundation Trust; and Julie Gough, Professor of Biomaterials and Tissue Engineering at The University of Manchester; presented their new polymer nerve conduit technology for the repair of severed nerves. This device has proven successful in animal models and funded by NIHR i4i is to be tested in ‘first in man’ clinical trials at UHSM in 2016.
Professor Guilo Cossu, Constance Thornley Professor of Regenerative Medicine at The University of Manchester, discussed his work in cell therapies and used the San Raffaele Hospital in Milan, as a case study of how regenerative medicine can be aided by organisational support in the form of physical proximity between regulatory offices, laboratories and clinical facilities. Drawing from his experiences of conducting clinical trials in Manchester and what he has learned from this previous experience, he suggested mechanisms through which the city’s institutions could facilitate future cell therapy trials in order to further promote cutting-edge technologies.
Michael Leverentz, Manchester Regenerative Medicine (MaRM) Network Project Manager, described the event as “inspiring”.
“Regenerative medicine is an important field of study that cuts across many of the MAHSC domains, particularly Inflammation and Repair and Women and Children, so I was very pleased to see the event fully booked and well attended by both researchers and clinicians.
“Through events like these, the MaRM Network and MAHSC hope to facilitate greater connection between research and clinical staff, so that ideas can be shared, new partnerships can be forged, and scientific discovery can be more easily translated from the laboratory to the care our patients receive.”